Literature DB >> 10604731

Pleuro-pulmonary tumours detected by clinical and chest X-ray analyses in rats transplanted with mesothelioma cells.

F Le Pimpec-Barthes1, I Bernard, I Abd Alsamad, A Renier, L Kheuang, J Fleury-Feith, P Devauchelle, F Quintin Colonna, M Riquet, M C Jaurand.   

Abstract

New strategies for cancer therapy must be developed, especially in severe neoplasms such as malignant pleural mesothelioma. Animal models of cancer, as close as possible to the human situation, are needed to investigate novel therapeutical approaches. Orthotopic transplantation of cancer cells is then relevant and efforts should be made to follow up tumour evolution in animals. In the present study, we developed a method for the orthotopic growth of mesothelioma cells in the pleural cavity of Fischer 344 and nude rats, along with a procedure for clinical survey. Two mesothelioma cell lines, of rat and human origin, were inoculated by transthoracic puncture. Body weight determination and chest X-ray analyses permitted the follow-up of tumour evolution by identifying different stages. Autopsies showed that tumours localized on the whole pleural cavity (diaphragm, parietal pleura), mediastinum and pericardium. Tumour morphology and antigenic characteristics were consistent with those of the inoculated cells and were similar in both types of rats inoculated with the same cell type. These results demonstrate that mesothelioma formation in rats can be followed up by clinical and radiographic survey after gentle intrathoracic inoculation of mesothelioma cells, thus allowing the definition of stages of interest for further experimental trials.

Entities:  

Mesh:

Year:  1999        PMID: 10604731      PMCID: PMC2362982          DOI: 10.1038/sj.bjc.6693248

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Gene therapy in the United States: a five-year status report.

Authors:  G Ross; R Erickson; D Knorr; A G Motulsky; R Parkman; J Samulski; S E Straus; B R Smith
Journal:  Hum Gene Ther       Date:  1996-09-10       Impact factor: 5.695

2.  Usefulness of the nude mouse model in mesothelioma based on a direct patient-xenograft comparison.

Authors:  A P Chahinian; P A Kirschner; R E Gordon; L Szrajer; J F Holland
Journal:  Cancer       Date:  1991-08-01       Impact factor: 6.860

Review 3.  Current progress in the gene therapy of cancer.

Authors:  B M Davis; O N Koc; K Lee; S L Gerson
Journal:  Curr Opin Oncol       Date:  1996-11       Impact factor: 3.645

4.  Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer.

Authors:  H C Hwang; W R Smythe; A A Elshami; J C Kucharczuk; K M Amin; J P Williams; L A Litzky; L R Kaiser; S M Albelda
Journal:  Am J Respir Cell Mol Biol       Date:  1995-07       Impact factor: 6.914

Review 5.  Biology of human colon cancer metastasis.

Authors:  M Gutman; I J Fidler
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 6.  Scheduling of chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.

Authors:  J F Bishop
Journal:  Lung Cancer       Date:  1995-06       Impact factor: 5.705

7.  Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion.

Authors:  P Astoul; J R Viallat; J C Laurent; M Brandely; C Boutin
Journal:  Chest       Date:  1993-01       Impact factor: 9.410

Review 8.  The epidermal growth factor receptor as a target for therapy in breast carcinoma.

Authors:  J Baselga; J Mendelsohn
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

9.  Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma.

Authors:  W R Smythe; L R Kaiser; H C Hwang; K M Amin; J M Pilewski; S J Eck; J M Wilson; S M Albelda
Journal:  Ann Thorac Surg       Date:  1994-06       Impact factor: 4.330

10.  Host organ specifically determines cancer progression.

Authors:  S Togo; H Shimada; T Kubota; A R Moossa; R M Hoffman
Journal:  Cancer Res       Date:  1995-02-01       Impact factor: 12.701

View more
  3 in total

1.  Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.

Authors:  Sonia Melo; Alberto Villanueva; Catia Moutinho; Veronica Davalos; Riccardo Spizzo; Cristina Ivan; Simona Rossi; Fernando Setien; Oriol Casanovas; Laia Simo-Riudalbas; Javier Carmona; Jordi Carrere; August Vidal; Alvaro Aytes; Sara Puertas; Santiago Ropero; Raghu Kalluri; Carlo M Croce; George A Calin; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-28       Impact factor: 11.205

2.  The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.

Authors:  Torry A Tucker; Candice Dean; Andrey A Komissarov; Kathy Koenig; Andrew P Mazar; Usha Pendurthi; Timothy Allen; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-27       Impact factor: 6.914

3.  Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis.

Authors:  Daniele Martarelli; Alfonso Catalano; Antonio Procopio; Sara Orecchia; Roberta Libener; Giorgio Santoni
Journal:  BMC Cancer       Date:  2006-05-17       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.